Are we Recognized

Absolutely!

The National Association of Pharmaceutical Sales Representatives represents experienced and entry-level sales rep nationally. The certification (CNPR) is a pharmaceutical sales certification program which is heavily marketed to the pharmaceutical industry. You can find information about the NAPSRx every month in Pharmaceutical Executive Magazine, which is circulated to over 70,000 current pharmaceutical representatives and managers. The CNPR examination and the NAPSRxs Training Manual was compiled by surveying the pharmaceutical industry and its members.

The NAPSRx has been highly recommended to the many individuals who are looking to break into the Pharmaceutical Sales industry as well as for advancing the careers of current pharmaceutical reps. If you are looking to gain entry into the industry, please review the areas of the website geared to entry-level sales. If you have any questions just email us at questions@napsronline.org.

The NAPSRxs education course is designed to provide the workforce skills necessary to acquire professional caliber positions in the pharmaceutical industry. The NAPSRx program is currently offered through over 300 colleges and universities (schools include: Ohio State University, University of Texas, Rutgers University, University of Mississippi, Indiana University, University of Colorado, plus hundreds more!) However, you can take advantage of the course now by ordering directly through the NAPSRx. If you want to find the college nearest you please email us at questions@napsronline.org.

The NAPSRxs Advisory Board and professional trainers have gained valuable experience from companies such as GlaxoSmithKline, Merck, Pfizer, Aventis, Abbot Laboratories, Forest Pharmaceuticals, Wyeth, TAP, Bausch & Lomb, Johnson & Johnson amongst many other major pharmaceutical companies. This expertise allows the NAPSRx to monitor, train and educate successfully.

The NAPSRx has also provided recruitment advertising to Eli Lilly, Schering-Plough, Andrx Laboratories, BIOGEN, Sanofi-Aventis, plus many more pharmaceutical companies.